NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
+32.66%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$2.33B
AUM Growth
+$2.33B
(+16%)
Cap. Flow
-$59.5M
Cap. Flow
% of AUM
-2.55%
Top 10 Holdings %
Top 10 Hldgs %
67.66%
Holding
50
New
8
Increased
6
Reduced
18
Closed
5
Top Buys
| 1 |
Praxis Precision Medicines
PRAX
|
$134M |
| 2 |
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
|
$121M |
| 3 |
Aligos Therapeutics
ALGS
|
$72.3M |
| 4 |
EAR
Eargo, Inc. Common Stock
EAR
|
$33M |
| 5 |
Galecto
GLTO
|
$31.2M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$221M |
| 2 |
Medtronic
MDT
|
$103M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$65.4M |
| 4 |
Apple
AAPL
|
$28.5M |
| 5 |
SI-BONE Inc
SIBN
|
$16.6M |
Sector Composition
| 1 | Healthcare | 65.57% |
| 2 | Technology | 5.9% |
| 3 | Financials | 5.43% |
| 4 | Communication Services | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $376M | 16.14% | 1,933,900 -1,136,500 | -37% | -$221M |
|
2
Nkarta
NKTX
$151M
| $172M | 7.36% | 2,793,864 | – | – |
|
3
Inogen
INGN
$216M
| $159M | 6.8% | 3,549,320 | – | – |
|
|
4
Apple
AAPL
$3.45T
| $138M | 5.9% | 1,037,404 -214,700 | -17% | -$28.5M |
|
|
5
Praxis Precision Medicines
PRAX
$958M
| $134M | 5.76% | +2,442,080 | New | +$134M |
|
6
Harmony Biosciences
HRMY
$2.12B
| $131M | 5.61% | 3,622,471 -132,502 | -4% | -$4.79M |
|
7
Brookfield
BN
$98.3B
| $127M | 5.43% | 3,070,957 | – | – |
|
|
SPRB
8
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $121M | 5.2% | +4,989,336 | New | +$121M |
|
9
Cable One
CABO
$909M
| $117M | 5% | 52,341 -4,950 | -9% | -$11M |
|
|
CTLT
10
DELISTED
CATALENT, INC.
CTLT
| $104M | 4.45% | 997,349 -628,651 | -39% | -$65.4M |
|
|
MORF
11
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $88.8M | 3.81% | 2,645,446 | – | – |
|
|
12
Aligos Therapeutics
ALGS
$73.3M
| $72.3M | 3.1% | +2,614,563 | New | +$72.3M |
|
|
INZY
13
DELISTED
Inozyme Pharma
INZY
| $53M | 2.27% | 2,569,379 | – | – |
|
|
FRLN
14
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $43.1M | 1.85% | 2,361,229 +1,696,229 | +255% | +$31M |
|
15
Mirum Pharmaceuticals
MIRM
$3.71B
| $42.7M | 1.83% | 2,445,147 | – | – |
|
16
Amicus Therapeutics
FOLD
$2.34B
| $38.9M | 1.67% | 1,684,795 -635,231 | -27% | -$14.7M |
|
|
EAR
17
DELISTED
Eargo, Inc. Common Stock
EAR
| $33M | 1.42% | +737,071 | New | +$33M |
|
|
CMPI
18
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $31.7M | 1.36% | 2,170,100 | – | – |
|
|
19
Galecto
GLTO
$4.21M
| $31.2M | 1.34% | +2,497,791 | New | +$31.2M |
|
|
GRTX
20
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $30.3M | 1.3% | 2,959,021 -450,000 | -13% | -$4.6M |
|
|
SPNE
21
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $23.4M | 1% | 1,339,085 -338,407 | -20% | -$5.91M |
|
|
BPMC
22
DELISTED
Blueprint Medicines
BPMC
| $22.1M | 0.95% | 197,000 -37,979 | -16% | -$4.26M |
|
|
VRNA
23
Verona Pharma
VRNA
$9.16B
| $18.3M | 0.78% | 2,608,755 +808,008 | +45% | +$5.66M |
|
24
Iovance Biotherapeutics
IOVA
$807M
| $17.8M | 0.76% | 384,117 -821 | -0.2% | -$38.1K |
|
25
Protagonist Therapeutics
PTGX
$3.67B
| $17.5M | 0.75% | 867,724 +73,355 | +9% | +$1.48M |
|